Russian pneumonic plague scare: What it means for India - The Indian Express

Reports from Russia about the death of a 28-year-old laboratory worker in Irkutsk have raised concerns about a possible case of pneumonic plague and prompted questions about whether the disease could pose a wider public health threat. The case has generated particular attention because the woman reportedly worked at an anti-plague research institute and was said to have had a possible laboratory exposure.

Russia’s public health authorities have described the illness as pneumonia of unknown aetiology (cause or origin) and said testing did not identify micro-organisms associated with her professional activities. People considered potentially exposed have reportedly been placed under medical observation. Nevertheless, pneumonic plague is one of the most serious forms of plague because it affects the lungs and can spread between people through respiratory droplets.

“For India, the practical clinical message is therefore two-fold: There is no reason for public alarm based on the Russian reports alone, but clinicians should recognise the disease quickly if a genuinely compatible case presents. Pneumonic plague is rare, but it is one of the infections in which early recognition and rapid public health action matter enormously,” says Dr Jatin Ahuja, infectious disease specialist, Indraprastha Apollo Hospital, New Delhi, explains.

This is a severe lung infection caused by the bacteria Yersinia pestis. While bubonic plague attacks the lymph nodes (causing swollen lumps called buboes) and septicemic plague infects the bloodstream, pneumonic plague infects the lungs. It is the only form of plague that spreads directly from person to person through the air.

It does not linger in the air like measles or spread as easily as the flu. It spreads through heavy respiratory droplets when an infected person coughs or spits blood. The greatest risk is being within 6 feet (2 meters) of a coughing patient without a mask, caring for them directly, or performing medical procedures on their airway.

Symptoms appear quickly, usually within one to three days (range: one to seven days). It begins suddenly with high fever, chills, severe headache and extreme weakness, rapidly followed by shortness of breath, chest pain, and a cough that brings up watery, blood-tinged, or pinkish phlegm.

Standard antibiotics (such as gentamicin, ciprofloxacin, or doxycycline) cure it very effectively, but timing is critical. Treatment must start within 24 hours of the first symptoms. Because lung damage progresses rapidly, delaying treatment beyond the first day dramatically raises the risk of death.

Health officials immediately place the patient in isolated, negative-pressure rooms and wear protective gear (N95 masks). They track down everyone who was in close contact, give them preventive antibiotic pills for 7 days, and monitor their temperature twice daily. Sputum and blood samples are rushed to reference labs for confirmation.

The risk is virtually zero. Because people only transmit it once they are visibly very sick, it is difficult for an infected person to travel undetected on long international journeys. For the risk to change, there would need to be widespread, uncontrolled outbreaks spreading through major international transport hubs.

India’s Port Health Organisations screen incoming international travelers at airports. If an inbound passenger falls severely ill, the flight crew alerts air traffic control, and the plane is directed to an isolation bay. The passenger is transferred by a specialized biocontainment ambulance to designated infectious disease hospitals (like AIIMS or Safdarjung), fellow passengers seated nearby are traced and given preventive antibiotics, and samples are tested at the National Centre for Disease Control (NCDC).

Initial symptoms look identical to standard viral flu or pneumonia, which is a diagnostic challenge. However, hospitals ask for recent international travel history for any rapidly deteriorating lung infection. Indian tertiary and government referral centers have standard stockpiles of effective antibiotics (ciprofloxacin, levofloxacin, gentamicin) and established isolation protocols developed during the COVID-19 pandemic.

The most important clinical issue raised by the Russian episode is that pneumonic plague can initially look like much more common respiratory illnesses. Fever, cough, breathlessness and pneumonia are not, by themselves, specific for plague.The epidemiological history can, therefore, become critical.

A rapidly deteriorating patient should be asked about recent international travel, residence in or travel to an area where plague occurs, contact with rodents or potentially infected animals, flea exposure, laboratory or occupational exposure, and close contact with a person suspected of having pneumonic plague. That history can change the differential diagnosis and determine whether urgent public-health notification and specialised testing are warranted.

The Russian reports have generated concern because of the laboratory worker’s occupation and the possibility of exposure. But unless Russian authorities confirm Yersinia pestis infection and evidence of transmission, describing the event as a “pneumonic-plague outbreak” would overstate what is currently known.The significance of pneumonic plague lies in its potential for rapid progression and person-to-person transmission — not in evidence that such transmission is currently occurring internationally.

The risk assessment would change if there was credible evidence of confirmed pneumonic-plague cases accompanied by secondary transmission, particularly sustained community transmission or clusters across multiple locations.That is different from an isolated suspected case, including one involving a laboratory exposure.

Unlike rapidly evolving RNA viruses, Yersinia pestis does not typically undergo dramatic genetic change over days or weeks. In a suspected pneumonic-plague event, the immediate concern is, therefore, not rapid mutation but whether the bacterium is actually present, whether it is transmitting between people, and whether it remains susceptible to effective antibiotics.